Prolactin down-regulates CD4 +CD25 hiCD127 low/- regulatory T cell function in humans

Journal of Molecular Endocrinology

Volumn 48, Issue 1, 2012, Pages 77-85

  Legorreta Haquet, M V ^a   Chavez Rueda K ^a   Montoya Diaz E ^a   Arriaga Pizano, L ^b   Silva Garcia R ^a   Chavez Sanchez L ^a   Moreno Lafont, M ^c   Zenteno Galindo, E ^d   Blanco Favela, F ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR; MONOCLONAL ANTIBODY CD28; PROLACTIN; PROLACTIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COCULTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ADULT; ANTIGENS, CD4; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MIDDLE AGED; PROLACTIN; RECEPTORS, PROLACTIN; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 84856997459     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0040     Document Type: Article

References (39)

1. Annunziato F, Cosmi L, Lazzeri E, Manetti R, Liotta F, Vanini V, Romagnani P, Maggi E & Romagnani S 2002 Phenotype, localization, and mechanism of suppression of CD4 C CD25 C human thymocytes. Journal of Experimental Medicine 196 379-387. (doi:10.1084/jem.20020110)
2. Asseman C, Mauze S, Leach MW, Coffman RL & Powrie F 1999 An essential role for interleukin 10 in the function of regulatory Tcells that inhibit intestinal inflammation. Journal of Experimental Medicine 190 995-1004. (doi:10.1084/jem.190.7.995)
3. Blanco F, Quintal G & Leaños A 1999 Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. Journal of Rheumatology 26 55-59.
4. Bole-Feysot C, Goffin V, Edery M, Binart N & Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews 19 225-268. (doi:10.1210/er.19.3.225)
5. Buckner JH 2010 Mechanisms of impaired regulation by CD4(C) CD25(C)FOXP3(C) regulatory T cells in human autoimmune diseases. Nature Reviews. Immunology 10 849-859. (doi:10.1038/ nri2889)
6. Caretto D, Katzman SD, Villarino AV, Gallo E & Abbas AK 2010 Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. Journal of Immunology 184 30-34. (doi:10.4049/ jimmunol.0903412)
7. Carreño PC, Sacodon R, Jimenez E, Vicente A & Zapata AG 2005 Prolactin affects both survival and differentiation of T-cell progenitors. Journal of Neuroimmunology 160 135-145. (doi:10.1016/ j.jneuroim.2004.11.008)
8. Chávez-Rueda K, Hernández J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV & Blanco-Favela F 2005 Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clinical Immunology 116 182-191. (doi:10. 1016/j.clim.2005.03.013)
9. Chávez-Rueda K, Legorreta-Haquet VM, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, Chávez-Sanchez L & Blanco-Favela F 2007 Effect of prolactin on lymphocyte activation from systemic lupus erythematosus patients. Annals of the New York Academy of Sciences 1108 157-165. (doi:10.1196/annals.1422.018)
10. Crispin JC, Martinez A & Alcocer-Varela J 2003 Quantification of regulatory T cells in patients with systemic lupus erythematosus. Journal of Autoimmunity 3 273-276. (doi:10.1016/S0896-8411(03) 00121-5)
11. De Bellis A, Bizzarro A, Pivonello R, Lombardi G & Bellastella A 2005 Prolactin and autoimmunity. Pituitary 8 25-30. (doi:10.1007/ s11102-005-5082-5)
12. Dejaco C, Duftner C, Grubeck-Loebenstein B & Schirmer M 2006 Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117 289-300. (doi:10.1111/j.1365-2567.2005.02317.x)
13. Gerlo S, Verdood P, Hooghe-Peters EL & Kooijman R 2006 Multiple cAMP-induced signalling cascades regulate prolactin expression in T cells. Cellular and Molecular Life Sciences 63 92-99. (doi:10.1007/ s00018-005-5433-4)
14. Jara LJ, Benitez G & Medina G 2008 Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmunity Reviews 7 251-255. (doi:10.1016/j.autrev.2007.11.018)
15. Jara LJ, Medina G, Saavedra MA, Vera-Lastra O & Navarro C 2009 Prolactin and autoimmunity. Clinical Reviews in Allergy&Immunology 6 516-519. (doi:10.1007/s12016-009-8182-3)
16. Kelchtermans H, De Klerck B, Mitera T, Van Balen M, Bullens D, Billiau A, Leclercq G & Matthys P 2005 Defective CD4 CCD25 C regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Research & Therapy 7 R402-R415. (doi:10. 1186/ar1500)
17. Kelley KW, Weigent DA & Kooijman R 2007 Protein hormones and immunity. Brain, Behavior, and Immunity 21 384-392. (doi:10.1016/ j.bbi.2006.11.010)
18. Le NT & Chao N 2007 Regulating regulatory T cells. Bone Marrow Transplantation 39 1-9. (doi:10.1038/sj.bmt.1705529)
19. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B et al. 2006 CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4(C) T reg cells. Journal of Experimental Medicine 203 1701-1711. (doi:10.1084/jem.20060772)
20. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ & Powrie F 2003 CD4 CCD25 CT(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. Journal of Experimental Medicine 197 111-119. (doi:10.1084/jem.20021345)
21. Montgomery DW 2001 Prolactin production by immune cells. Lupus 10 665-675. (doi:10.1191/096120301717164895)
22. Mottet C, Uhlig HH & Powrie F 2003 Cutting edge: cure of colitis by CD4 CCD25 C regulatory T cells. Journal of Immunology 170 3939-3943.
23. Mudd PA, Teague BN & Farris AD 2006 Regulatory T cells and systemic lupus erythematosus. Scandinavian Journal of Immunology 64 211-218. (doi:10.1111/j.1365-3083.2006.01808.x)
24. Nagar M, Jacob-Hirsch J, Vernitsky H, Berkun Y, Ben-Horin S, Amariglio N, Bank I, Kloog Y, Rechavi G & Goldstein I 2010 TNF activates a NF-kappa B-regulated cellular program in human CD45 RA-regulatory T cells that modulates their suppressive function. Journal of Immunology 184 3570-3581. (doi:10.4049/ jimmunol.0902070)
25. Nakamura K, Kitani A & Strober W 2001 Cell contact-dependent immunosuppression by CD4 CCD25 C regulatory Tcells is mediated by cell surface-bound transforming growth factor beta. Journal of Experimental Medicine 194 629-644. (doi:10.1084/jem.194.5.629)
26. Nociti V, Frisullo G, Tartaglione T, Patanella AK, Iorio R, Tonali PA & Batocchi AP 2010 Multiple sclerosis attacks triggered by hyper prolactinemia. Journal of Neuro-oncology 98 407-409. (doi:10.1007/ s11060-009-0076-1)
27. Saha S, González J, Rosenfeld G, Keiser H & Peeva E 2009 Prolactin alters the mechanisms of B cell tolerance induction. Arthritis and Rheumatism 60 1743-1752. (doi:10.1002/art.24500)
28. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P & Yamaguchi T 2009 Regulatory T cells: how do they suppress immune responses? International Immunology 21 1105-1111. (doi:10.1093/intimm/ dxp095)
29. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A & Bluestone JA 2000 B7/CD28 costimulation is essential for the homeostasis of the CD4 CCD25 C immunoregulatory T cells that control autoimmune diabetes. Immunity 12 431-440. (doi:10.1016/ S1074-7613(00)80195-8)
30. Scheinecker C, Bonelli M & Smolen JS 2010 Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. Journal of Autoimmunity 35 269-275. (doi:10.1016/j.jaut.2010. 06.018)
31. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R et al. 2006 Expression of interleukin IL-2 and IL-7 receptors discriminates between human regulatory and activated T cells. Journal of Experimental Medicine 203 1693-1700. (doi:10.1084/jem. 20060468)
32. Sojka DK, Huang YH & Fowell DJ 2008 Mechanisms of regulatory Tcell suppression a diverse arsenal for a moving target. Immunology 124 13-22. (doi:10.1111/j.1365-2567.2008.02813.x)
33. Takizawa K, Kitani S, Takeuchi F & Yamamoto K 2005 Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocrine Journal 52 635-641. (doi:10.1507/endocrj.52.635)
34. Thornton AM & Shevach EM 1998 CD4 CCD25 C immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. Journal of Experimental Medicine 188 287-296. (doi:10.1084/jem.188.2.287)
35. Tomio A, Schust DJ, Kawana K, Yasugi T, Kawana Y, Mahalingaiah S, Fujii T & Taketani Y 2008 Prolactin can modulate CD4 CT-cell response through receptor-mediated alterations in the expression of T-bet. Immunology and Cell Biology 86 616-621. (doi:10.1038/icb. 2008.29)
36. Tower C, Crocker I, Chirico D, Baker P & Bruce I 2011 SLE and pregnancy: the potential role for regulatory T cells. Nature Reviews. Rheumatology 7 124-128. (doi:10.1038/nrrheum.2010.124)
37. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM & Lipsky PE 2006 TNF down modulates the function of human CD4 CCD25hi T-regulatory cells. Blood 108 253-261. (doi:10.1182/ blood-2005-11-4567)
38. Wood KJ & Sawitzki B 2006 Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends in Immunology 27 183-187. (doi:10.1016/j.it.2006.02.008)
39. Xu D, Lin L, Lin X, Huang Z & Lei Z 2010 Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown. Cellular Immunology 263 71-78. (doi:10.1016/j.cellimm. 2010.02.018)